The immunotherapy-based combination associated score as a robust predictor for outcome and response to combination of immunotherapy and VEGF inhibitors in renal cell carcinoma
This study has collectively developed an immunotherapy-based combination associated score, pinpointed effective biomarkers for prognostic and responsiveness of kidney cancer patients to immunotherapy-based combinations, and delved into their potential biological mechanisms, offering promising targets for further exploration.
Authors
- Kaiyue Li (ORCID: https://orcid.org/0000-0001-5998-7397)
- Huiyang Yuan
- Wenqiang Qi
- Lipeng Chen (ORCID: https://orcid.org/0000-0002-5655-7268)
- Maolin Zang
- Zhengfang Liu (ORCID: https://orcid.org/0000-0003-4053-8430)
- Yan Zhang (ORCID: https://orcid.org/0000-0002-7989-4822)
Institutions
- Shandong University (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Computers in Biology and Medicine
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1016/j.compbiomed.2024.109210
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Basic and Applied Basic Research Foundation of Guangdong Province